Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:37 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2CompletedINTERVENTIONAL

The Role of Vasopressin in the Social Deficits of Autism

ClinicalTrials.gov · NCT01962870 · Registry updated: 2019-05-24

Condition / research focus: Autism Spectrum Disorders
Sponsor: Stanford University
Countries with listed sites: United States
Registry dates and results: Start: 2013-12. Completion: 2017-05-30 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Stanford University School of Medicine; Psychiatry and Behavioral Sciences
Stanford, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock

ClinicalTrials.gov · NCT01611935 · Registry updated: 2019-05-21

Condition / research focus: Traumatic Shock
Sponsor: University of Pennsylvania
Countries with listed sites: United States
Registry dates and results: Start: 2013-05-01. Completion: 2016-09-06 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)

Where the study takes place — 1 listed sites

Hospital at the Unversity of Pennyslvania
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

To Evaluate the Renal Tubular Function Pre and Post Nephrectomy in Living Donors

ClinicalTrials.gov · NCT03676361 · Registry updated: 2019-05-20

Condition / research focus: Kidney Damage
Sponsor: University of Kansas Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2018-08-29. Completion: 2019-04-26 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)

Where the study takes place — 1 listed sites

University of Kansas Medical Center
Kansas City, Kansas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Decision Support for Intraoperative Low Blood Pressure

ClinicalTrials.gov · NCT02726620 · Registry updated: 2019-05-16

Condition / research focus: Hypotension
Sponsor: Vanderbilt University Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2017-01-05. Completion: 2018-12-29 (may be estimated). Results are posted in this registry.

Products and interventions (44)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Attending real-time decision support (procedure)
In-room real-time decision support (procedure)
Attending feedback emails (procedure)
In-room provider feedback emails (procedure)
Anesthesia Information Management System (AIMS) (device)
Perioperative Data Warehouse (PDW) (device)
General anesthesia (procedure)
Pager system (device)
Central neuraxial anesthesia (procedure) — also listed as: Regional anesthesia, Spinal anesthesia, Intrathecal anesthesia, Subarachnoid anesthesia, Epidural anesthesia, Central neuraxial blockade
Non-cardiac surgery (procedure)
Propofol (drug)
Sevoflurane (drug)
Desflurane (drug)
Isoflurane (drug)
Ephedrine (drug)
Phenylephrine (drug)
Norepinephrine (drug)
Epinephrine (drug)
Dobutamine (drug)
Dopamine (drug)
Isoproterenol (drug)
Milrinone (drug)
Atropine (drug)
Glycopyrrolate (drug)
Vasopressin (drug)
Terlipressin (drug)
Sodium Chloride 0.9% (drug)
Ringer's lactate (drug)
Hydroxyethyl starch solutions (drug)
Fresh Frozen Plasma (drug)
Packed Red Blood Cells (drug)
Albumin solutions (drug)
Plasma-Lyte (drug)
Lidocaine (drug) — also listed as: Lignocaine
Bupivacaine (drug)
Levobupivacaine (drug)
Ropivacaine (drug)
Mepivacaine (drug)
Tetracaine (drug)
Prilocaine (drug)
Procaine (drug)
Chloroprocaine (drug)
Benzocaine (drug)
Articaine (drug)

Where the study takes place — 1 listed sites

Vanderbilt University Medical Center
Nashville, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Topical Tranexamic Acid Plus Perivascular Vasopressin at the Time of Abdominal Myomectomy

ClinicalTrials.gov · NCT03880045 · Registry updated: 2019-05-13

Condition / research focus: Myoma
Sponsor: Aswan University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-04-01. Completion: 2021-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Topical TA (drug) — also listed as: Active comparator
vasopressin (drug) — also listed as: Active Comparator
placebo to TA (other) — also listed as: placebo comparator

Where the study takes place — 1 listed sites

Aswan University Hospital
Aswān, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Vasopressin Injection Versus Misoprostol During Hysteroscopic Myomectomy In Reducing Blood Loss And Operation Time.

ClinicalTrials.gov · NCT03930069 · Registry updated: 2019-04-29

Condition / research focus: Submucous Leiomyoma of Uterus
Sponsor: Zagazig University
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-05-02. Completion: 2017-03-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Misotac
Vasopressin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

The Role of Vasopressin Antagonism on Renal Sodium Handling

ClinicalTrials.gov · NCT03910231 · Registry updated: 2019-04-10

Condition / research focus: Healthy
Sponsor: Brigham and Women's Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2012-02-01. Completion: 2015-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolvaptan Oral Tablet (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Low Von Willebrand in Ireland Cohort Study

ClinicalTrials.gov · NCT03167320 · Registry updated: 2019-03-28

Condition / research focus: Von Willebrand Factor, Deficiency
Sponsor: St. James's Hospital, Ireland
Countries with listed sites: Ireland
Registry dates and results: Start: 2014-10. Completion: 2022-07 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

St. James's Hospital
Dublin, Ireland
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Optimal VAsopressor titraTION Pilot Randomized Controlled Trial

ClinicalTrials.gov · NCT01800877 · Registry updated: 2019-03-12

Condition / research focus: Hypotension; Shock
Sponsor: Francois Lamontagne
Countries with listed sites: Canada · United States
Registry dates and results: Start: 2013-04. Completion: 2015-02 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressors (drug) — also listed as: phenylephrine, dopamine, norepinephrine, epinephrine, vasopressin

Where the study takes place — 10 listed sites

Mercy Hospital
St Louis, Missouri, United States
Site recruitment: Not reported
University of Alberta Hospital
Edmonton, Alberta, Canada
Site recruitment: Not reported
Queens Elizabeth II Hospital
Halifax, Nova Scotia, Canada
Site recruitment: Not reported
Kingston General Hospital
Kingston, Ontario, Canada
Site recruitment: Not reported
The Ottawa Hospital
Ottawa, Ontario, Canada
Site recruitment: Not reported
Mt Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported
Sunnybrooke HSC
Toronto, Ontario, Canada
Site recruitment: Not reported
Toronto General Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported
Hopital L'Enfant-Jesus
Québec, Quebec, Canada
Site recruitment: Not reported
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Evaluation of Copeptin Levels in Elective Cesarean Section With Different Anesthetic Technique

ClinicalTrials.gov · NCT03536910 · Registry updated: 2019-02-26

Condition / research focus: Fetal Distress
Sponsor: Istanbul University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2018-05-01. Completion: 2018-10-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Copeptin (other) — also listed as: Fetal distress

Where the study takes place — 1 listed sites

Istanbul University Cerrahpasa Medical Faculty
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Study of Dopamine Versus Vasopressin for Treatment of Low Blood Pressure in Low Birth Weight Infants

ClinicalTrials.gov · NCT01318278 · Registry updated: 2019-02-20

Condition / research focus: Hypotension
Sponsor: Baylor College of Medicine
Countries with listed sites: United States
Registry dates and results: Start: 2011-03. Completion: 2013-09 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dopamine (drug) — also listed as: Dopamine Hydrochloride
Arginine Vasopressin (drug) — also listed as: Vasopressin, Antidiuretic Hormone (ADH), Pitressin (US brand name), Pressyn;Pressyn AR (Canadian brand names), Argipressin

Where the study takes place — 1 listed sites

Texas Children's Hospital
Houston, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population

ClinicalTrials.gov · NCT02584231 · Registry updated: 2019-02-06

Condition / research focus: Monosymptomatic Nocturnal Enuresis
Sponsor: University Ghent
Countries with listed sites: Belgium
Registry dates and results: Start: 2015-09-09. Completion: 2019-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin (drug) — also listed as: dDAVP

Where the study takes place — 1 listed sites

Ghent University Hospital - Department of Paediatric Nephrology
Ghent, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation

ClinicalTrials.gov · NCT01036841 · Registry updated: 2019-02-06

Condition / research focus: Enuresis; Polyuria
Sponsor: University Hospital, Ghent
Countries with listed sites: Belgium
Registry dates and results: Start: 2009-12. Completion: 2010-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin tablet (drug)
desmopressin MELT formulation (drug)

Where the study takes place — 1 listed sites

University Hospital Ghent
Ghent, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock

ClinicalTrials.gov · NCT03014063 · Registry updated: 2019-01-31

Condition / research focus: Septic Shock
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2016-11. Completion: 2017-06 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Cleveland Clinic
Cleveland, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

High Water Intake in Polycystic Kidney Disease

ClinicalTrials.gov · NCT02933268 · Registry updated: 2019-01-15

Condition / research focus: Autosomal Dominant Polycystic Kidney Disease
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2016-09-26. Completion: 2018-07-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

High water intake (dietary_supplement)
Ad libitum water intake (other)

Where the study takes place — 1 listed sites

Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation

ClinicalTrials.gov · NCT03395574 · Registry updated: 2018-12-24

Condition / research focus: Terlipressin Adverse Reaction; Liver Transplantation
Sponsor: Kasr El Aini Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-01-25. Completion: 2018-11-25 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)
Normal saline (drug)

Where the study takes place — 1 listed sites

Kasr Alainy Hospital , Faculty of Medicine
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertension

ClinicalTrials.gov · NCT01370096 · Registry updated: 2018-12-19

Condition / research focus: Pulmonary Hypertension
Sponsor: University of Alberta
Countries with listed sites: Canada
Registry dates and results: Start: 2012-02. Completion: 2016-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin infusion (drug)
Vasopressin infusion and epoprostenol inhalation (drug) — also listed as: Flolan

Where the study takes place — 1 listed sites

Stollery Children's Hospital
Edmonton, Alberta, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study

ClinicalTrials.gov · NCT03336814 · Registry updated: 2018-11-29

Condition / research focus: Septic Shock
Sponsor: Assistance Publique Hopitaux De Marseille
Countries with listed sites: France
Registry dates and results: Start: 2018-07-27. Completion: 2019-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)
Placebo (other)

Where the study takes place — 1 listed sites

Assistance Publique - Hôpitaux de Marseille
Marseille, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Optimization of Hepatic Hemodynamics During Liver Surgery

ClinicalTrials.gov · NCT02993640 · Registry updated: 2018-11-08

Condition / research focus: Portal Blood Pressure; Liver Surgery; Hepatic Hemodynamics
Sponsor: Sahlgrenska University Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-09. Completion: 2017-03-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

vasopressin + nitro (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant

ClinicalTrials.gov · NCT00886262 · Registry updated: 2018-10-17

Condition / research focus: Liver Failure
Sponsor: Medical University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2007-07. Completion: 2011-08 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Normal saline placebo (drug)

Where the study takes place — 1 listed sites

Medical University of South Carolina
Charleston, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:37 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2CompletedINTERVENTIONAL

The Role of Vasopressin in the Social Deficits of Autism

ClinicalTrials.gov · NCT01962870 · Registry updated: 2019-05-24

Condition / research focus: Autism Spectrum Disorders
Sponsor: Stanford University
Countries with listed sites: United States
Registry dates and results: Start: 2013-12. Completion: 2017-05-30 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Stanford University School of Medicine; Psychiatry and Behavioral Sciences
Stanford, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock

ClinicalTrials.gov · NCT01611935 · Registry updated: 2019-05-21

Condition / research focus: Traumatic Shock
Sponsor: University of Pennsylvania
Countries with listed sites: United States
Registry dates and results: Start: 2013-05-01. Completion: 2016-09-06 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)

Where the study takes place — 1 listed sites

Hospital at the Unversity of Pennyslvania
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

To Evaluate the Renal Tubular Function Pre and Post Nephrectomy in Living Donors

ClinicalTrials.gov · NCT03676361 · Registry updated: 2019-05-20

Condition / research focus: Kidney Damage
Sponsor: University of Kansas Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2018-08-29. Completion: 2019-04-26 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)

Where the study takes place — 1 listed sites

University of Kansas Medical Center
Kansas City, Kansas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Decision Support for Intraoperative Low Blood Pressure

ClinicalTrials.gov · NCT02726620 · Registry updated: 2019-05-16

Condition / research focus: Hypotension
Sponsor: Vanderbilt University Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2017-01-05. Completion: 2018-12-29 (may be estimated). Results are posted in this registry.

Products and interventions (44)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Attending real-time decision support (procedure)
In-room real-time decision support (procedure)
Attending feedback emails (procedure)
In-room provider feedback emails (procedure)
Anesthesia Information Management System (AIMS) (device)
Perioperative Data Warehouse (PDW) (device)
General anesthesia (procedure)
Pager system (device)
Central neuraxial anesthesia (procedure) — also listed as: Regional anesthesia, Spinal anesthesia, Intrathecal anesthesia, Subarachnoid anesthesia, Epidural anesthesia, Central neuraxial blockade
Non-cardiac surgery (procedure)
Propofol (drug)
Sevoflurane (drug)
Desflurane (drug)
Isoflurane (drug)
Ephedrine (drug)
Phenylephrine (drug)
Norepinephrine (drug)
Epinephrine (drug)
Dobutamine (drug)
Dopamine (drug)
Isoproterenol (drug)
Milrinone (drug)
Atropine (drug)
Glycopyrrolate (drug)
Vasopressin (drug)
Terlipressin (drug)
Sodium Chloride 0.9% (drug)
Ringer's lactate (drug)
Hydroxyethyl starch solutions (drug)
Fresh Frozen Plasma (drug)
Packed Red Blood Cells (drug)
Albumin solutions (drug)
Plasma-Lyte (drug)
Lidocaine (drug) — also listed as: Lignocaine
Bupivacaine (drug)
Levobupivacaine (drug)
Ropivacaine (drug)
Mepivacaine (drug)
Tetracaine (drug)
Prilocaine (drug)
Procaine (drug)
Chloroprocaine (drug)
Benzocaine (drug)
Articaine (drug)

Where the study takes place — 1 listed sites

Vanderbilt University Medical Center
Nashville, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Topical Tranexamic Acid Plus Perivascular Vasopressin at the Time of Abdominal Myomectomy

ClinicalTrials.gov · NCT03880045 · Registry updated: 2019-05-13

Condition / research focus: Myoma
Sponsor: Aswan University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-04-01. Completion: 2021-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Topical TA (drug) — also listed as: Active comparator
vasopressin (drug) — also listed as: Active Comparator
placebo to TA (other) — also listed as: placebo comparator

Where the study takes place — 1 listed sites

Aswan University Hospital
Aswān, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Vasopressin Injection Versus Misoprostol During Hysteroscopic Myomectomy In Reducing Blood Loss And Operation Time.

ClinicalTrials.gov · NCT03930069 · Registry updated: 2019-04-29

Condition / research focus: Submucous Leiomyoma of Uterus
Sponsor: Zagazig University
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-05-02. Completion: 2017-03-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Misotac
Vasopressin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

The Role of Vasopressin Antagonism on Renal Sodium Handling

ClinicalTrials.gov · NCT03910231 · Registry updated: 2019-04-10

Condition / research focus: Healthy
Sponsor: Brigham and Women's Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2012-02-01. Completion: 2015-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolvaptan Oral Tablet (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Low Von Willebrand in Ireland Cohort Study

ClinicalTrials.gov · NCT03167320 · Registry updated: 2019-03-28

Condition / research focus: Von Willebrand Factor, Deficiency
Sponsor: St. James's Hospital, Ireland
Countries with listed sites: Ireland
Registry dates and results: Start: 2014-10. Completion: 2022-07 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

St. James's Hospital
Dublin, Ireland
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Optimal VAsopressor titraTION Pilot Randomized Controlled Trial

ClinicalTrials.gov · NCT01800877 · Registry updated: 2019-03-12

Condition / research focus: Hypotension; Shock
Sponsor: Francois Lamontagne
Countries with listed sites: Canada · United States
Registry dates and results: Start: 2013-04. Completion: 2015-02 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressors (drug) — also listed as: phenylephrine, dopamine, norepinephrine, epinephrine, vasopressin

Where the study takes place — 10 listed sites

Mercy Hospital
St Louis, Missouri, United States
Site recruitment: Not reported
University of Alberta Hospital
Edmonton, Alberta, Canada
Site recruitment: Not reported
Queens Elizabeth II Hospital
Halifax, Nova Scotia, Canada
Site recruitment: Not reported
Kingston General Hospital
Kingston, Ontario, Canada
Site recruitment: Not reported
The Ottawa Hospital
Ottawa, Ontario, Canada
Site recruitment: Not reported
Mt Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported
Sunnybrooke HSC
Toronto, Ontario, Canada
Site recruitment: Not reported
Toronto General Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported
Hopital L'Enfant-Jesus
Québec, Quebec, Canada
Site recruitment: Not reported
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Evaluation of Copeptin Levels in Elective Cesarean Section With Different Anesthetic Technique

ClinicalTrials.gov · NCT03536910 · Registry updated: 2019-02-26

Condition / research focus: Fetal Distress
Sponsor: Istanbul University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2018-05-01. Completion: 2018-10-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Copeptin (other) — also listed as: Fetal distress

Where the study takes place — 1 listed sites

Istanbul University Cerrahpasa Medical Faculty
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Study of Dopamine Versus Vasopressin for Treatment of Low Blood Pressure in Low Birth Weight Infants

ClinicalTrials.gov · NCT01318278 · Registry updated: 2019-02-20

Condition / research focus: Hypotension
Sponsor: Baylor College of Medicine
Countries with listed sites: United States
Registry dates and results: Start: 2011-03. Completion: 2013-09 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dopamine (drug) — also listed as: Dopamine Hydrochloride
Arginine Vasopressin (drug) — also listed as: Vasopressin, Antidiuretic Hormone (ADH), Pitressin (US brand name), Pressyn;Pressyn AR (Canadian brand names), Argipressin

Where the study takes place — 1 listed sites

Texas Children's Hospital
Houston, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population

ClinicalTrials.gov · NCT02584231 · Registry updated: 2019-02-06

Condition / research focus: Monosymptomatic Nocturnal Enuresis
Sponsor: University Ghent
Countries with listed sites: Belgium
Registry dates and results: Start: 2015-09-09. Completion: 2019-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin (drug) — also listed as: dDAVP

Where the study takes place — 1 listed sites

Ghent University Hospital - Department of Paediatric Nephrology
Ghent, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation

ClinicalTrials.gov · NCT01036841 · Registry updated: 2019-02-06

Condition / research focus: Enuresis; Polyuria
Sponsor: University Hospital, Ghent
Countries with listed sites: Belgium
Registry dates and results: Start: 2009-12. Completion: 2010-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin tablet (drug)
desmopressin MELT formulation (drug)

Where the study takes place — 1 listed sites

University Hospital Ghent
Ghent, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock

ClinicalTrials.gov · NCT03014063 · Registry updated: 2019-01-31

Condition / research focus: Septic Shock
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2016-11. Completion: 2017-06 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Cleveland Clinic
Cleveland, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

High Water Intake in Polycystic Kidney Disease

ClinicalTrials.gov · NCT02933268 · Registry updated: 2019-01-15

Condition / research focus: Autosomal Dominant Polycystic Kidney Disease
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2016-09-26. Completion: 2018-07-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

High water intake (dietary_supplement)
Ad libitum water intake (other)

Where the study takes place — 1 listed sites

Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation

ClinicalTrials.gov · NCT03395574 · Registry updated: 2018-12-24

Condition / research focus: Terlipressin Adverse Reaction; Liver Transplantation
Sponsor: Kasr El Aini Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-01-25. Completion: 2018-11-25 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)
Normal saline (drug)

Where the study takes place — 1 listed sites

Kasr Alainy Hospital , Faculty of Medicine
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertension

ClinicalTrials.gov · NCT01370096 · Registry updated: 2018-12-19

Condition / research focus: Pulmonary Hypertension
Sponsor: University of Alberta
Countries with listed sites: Canada
Registry dates and results: Start: 2012-02. Completion: 2016-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin infusion (drug)
Vasopressin infusion and epoprostenol inhalation (drug) — also listed as: Flolan

Where the study takes place — 1 listed sites

Stollery Children's Hospital
Edmonton, Alberta, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study

ClinicalTrials.gov · NCT03336814 · Registry updated: 2018-11-29

Condition / research focus: Septic Shock
Sponsor: Assistance Publique Hopitaux De Marseille
Countries with listed sites: France
Registry dates and results: Start: 2018-07-27. Completion: 2019-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)
Placebo (other)

Where the study takes place — 1 listed sites

Assistance Publique - Hôpitaux de Marseille
Marseille, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Optimization of Hepatic Hemodynamics During Liver Surgery

ClinicalTrials.gov · NCT02993640 · Registry updated: 2018-11-08

Condition / research focus: Portal Blood Pressure; Liver Surgery; Hepatic Hemodynamics
Sponsor: Sahlgrenska University Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-09. Completion: 2017-03-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

vasopressin + nitro (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant

ClinicalTrials.gov · NCT00886262 · Registry updated: 2018-10-17

Condition / research focus: Liver Failure
Sponsor: Medical University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2007-07. Completion: 2011-08 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Normal saline placebo (drug)

Where the study takes place — 1 listed sites

Medical University of South Carolina
Charleston, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →